BECLOFORTE INHALER - AEM INH 250MCG/AEM 250 MCG
BECLOMETHASONE DIPROPIONATE : 250 MCG · DIN 02215055 · GLAXO WELLCOME INC.
Health Canada status: CANCELLED POST MARKET
What is BECLOFORTE INHALER - AEM INH 250MCG/AEM?
BECLOFORTE INHALER - AEM INH 250MCG/AEM 250 MCG contains BECLOMETHASONE DIPROPIONATE : 250 MCG. It is listed in the Health Canada Drug Product Database under DIN 02215055, held by GLAXO WELLCOME INC., supplied as METERED-DOSE AEROSOL for INHALATION administration. Health Canada currently lists it as cancelled post market, status dated 24-May-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is BECLOFORTE INHALER - AEM INH 250MCG/AEM called?
The same molecule, BECLOMETASONE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Trimbow | Latin | Australia |
| CORTIVENT | Latin | Morocco |
| Fostair | Latin | Australia |
| MIFLASONE | Latin | Morocco |
| AIRCORT | Latin | Morocco |
| BECLOJET | Latin | Morocco |
| BECONASE | Latin | Morocco |
| CLENIDERM | Latin | Morocco |
| CLENIL FORTE | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02215055 |
|---|---|
| Brand name | BECLOFORTE INHALER - AEM INH 250MCG/AEM |
| Generic / active ingredient | BECLOMETHASONE DIPROPIONATE : 250 MCG |
| Manufacturer | GLAXO WELLCOME INC. |
| Strength | 250 MCG |
| Dosage form | METERED-DOSE AEROSOL |
| Route of administration | INHALATION |
| Schedule | Prescription |
| ATC code | R03BA01 BECLOMETASONE |
| AHFS class | 68:04.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 24-May-2000 |
| Original market date | 1997-02-11 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02215055 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2215055 |
| Brand name | BECLOFORTE INHALER - AEM INH 250MCG/AEM |
| Active ingredient / INN | BECLOMETHASONE DIPROPIONATE : 250 MCG |
| ATC code | R03BA01 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R03 |
| AHFS class | 68:04.00 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | GLAXO WELLCOME INC. |
Which pack is which?
| Strength on the label | 250 MCG |
|---|---|
| Dosage form | METERED-DOSE AEROSOL |
| Route | INHALATION |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code R03BA01 BECLOMETASONE. 2 of 17 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| QVAR | 100 MCG | METERED-DOSE AEROSOL | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02242030 |
| QVAR | 50 MCG | METERED-DOSE AEROSOL | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02242029 |
| ALTI-BECLOMETHASONE DIPROPIONATE INHALER 50MCG/MD | 50 MCG | METERED-DOSE AEROSOL | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 00872334 |
| BECLODISK - PWR INH 100MCG/BLISTER | 100 MCG | POWDER | GLAXO WELLCOME INC. | CANCELLED POST MARKET | DIN 02213710 |
| BECLODISK - PWR INH 200MCG/BLISTER | 200 MCG | POWDER | GLAXO WELLCOME INC. | CANCELLED POST MARKET | DIN 02213729 |
| BECLODISK PWR 100MCG/BLISTER | 100 MCG | POWDER | GLAXO CANADA INC | CANCELLED POST MARKET | DIN 00828521 |
| BECLODISK PWR 200MCG/BLISTER | 200 MCG | POWDER | GLAXO CANADA INC | CANCELLED POST MARKET | DIN 00828548 |
| BECLOFORTE 250MCG/AEM | 250 MCG | METERED-DOSE AEROSOL | GLAXO CANADA INC | CANCELLED POST MARKET | DIN 00897353 |
| BECLOMETHASONE DIPROPIONATE ORAL INHALER | 50 MCG | METERED-DOSE AEROSOL | PHARMACO CANADA INC. | CANCELLED POST MARKET | DIN 02079976 |
| BECLOVENT - AEM 50MCG/AEM | 50 MCG | METERED-DOSE AEROSOL | GLAXO WELLCOME INC. | CANCELLED POST MARKET | DIN 02216531 |
Who else supplies BECLOMETASONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BECLOMETASONE appears in 1496 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does BECLOMETASONE cost around the world?
BECLOMETASONE is listed on 6 national price registers Nexara tracks, across 61 pack listings published on 6 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Australia | ex-manufacturer | 9 | 22 | 08 Sep 2026 |
| Morocco | PPV (public price) | 9 | 15 | 05 Sep 2026 |
| Italy | prezzo al pubblico (classe A) | 13 | 13 | 02 Sep 2026 |
| Greece | producer price (ex-factory) | 9 | 9 | 03 Sep 2026 |
| United Kingdom | hospital | 1 | 1 | 31 Aug 2026 |
| South Africa | single exit price | 1 | 1 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.